Inflammation in end-stage renal disease: the hidden enemy (Q36410507)

14 August 2017

1 reference

title

Inflammation in end-stage renal disease: the hidden enemy (English)

1 reference

14 August 2017

0 references

1 reference

1

Peter Stenvinkel

1 reference

14 August 2017

1 February 2006

1 reference

14 August 2017

1 reference

14 August 2017

11

1 reference

14 August 2017

36-41

1 reference

14 August 2017

1

1 reference

Chronic kidney disease as cause of cardiovascular morbidity and mortality

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Low triiodothyronine: a new facet of inflammation in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Biomarkers of inflammation and progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Inflammation, malnutrition and atherosclerosis in end-stage renal disease: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Traditional cardiac risk factors in individuals with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Survival advantage in Asian American end-stage renal disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Association of fish intake and survival in a cohort of incident dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Novel approaches in an integrated therapy of inflammatory-associated wasting in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

End-stage renal disease--not an equal opportunity disease: the role of genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Causes and therapy of microinflammation in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

When good water goes bad: how it happens, clinical consequences and possible solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Is biofilm a cause of silent chronic inflammation in haemodialysis patients? A fascinating working hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

C-reactive protein and chronic Chlamydia pneumoniae infection--long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Association of helicobacter pylori infection with nutritional status in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Importance of periodontal disease in the kidney patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Associations between circulating inflammatory markers and residual renal function in CRF patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

The role of tumor necrosis factor in the pathophysiology of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2006.00541.X

10.1111/J.1440-1797.2006.00541.X

21 January 2018

Identifiers

DOI

1 reference

release_ide3bu7xuzcprk57pgwb4ppl5y

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ide3bu7xuzcprk57pgwb4ppl5y

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16509930

1 reference

PubMed ID

16509930